Prelude Capital Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,601
| Closed | -$631K | – | 1502 |
|
|
2021
Q4 | $631K | Buy |
+1,601
| New | +$631K | 0.02% | 666 |
|
|
2021
Q3 | – | Sell |
-3,191
| Closed | -$1.24M | – | 1372 |
|
|
2021
Q2 | $1.24M | Sell |
3,191
-362
| -10% | -$141K | 0.04% | 384 |
|
|
2021
Q1 | $1.28M | Buy |
+3,553
| New | +$1.28M | 0.03% | 303 |
|
|
2020
Q4 | – | Sell |
-4
| Closed | -$1K | – | 813 |
|
|
2020
Q3 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 1284 |
|
|
2018
Q4 | – | Sell |
-89
| Closed | -$92K | – | 1388 |
|
|
2018
Q3 | $92K | Buy |
+89
| New | +$92K | 0.01% | 694 |
|
|
2017
Q4 | – | Sell |
-529
| Closed | -$219K | – | 1215 |
|
|
2017
Q3 | $219K | Buy |
+529
| New | +$219K | 0.02% | 556 |
|